BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6187447)

  • 1. Terminal incorporation of 2'-deoxyadenosine into polyadenylate segments of polyadenylated RNA in G1-phase-arrested human T-lymphoblasts.
    Kefford RF; Fox RM; McCairns E; Fahey D; Muscat GE; Rowe PB
    Cancer Res; 1983 May; 43(5):2252-7. PubMed ID: 6187447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. G1-phase arrest of cultured human leukemic T-cells induced by deoxyadenosine.
    Fox RM; Kefford RF; Tripp EH; Taylor IW
    Cancer Res; 1981 Dec; 41(12 Pt 1):5141-50. PubMed ID: 6272990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of deoxyadenosine toxicity in hybrids between human T- and B- lymphoblasts as a model for the development of drug resistance in T-cell acute lymphoblastic leukemia.
    Kurtzberg J; Hershfield MS
    Cancer Res; 1985 Apr; 45(4):1579-86. PubMed ID: 3872167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of cytotoxicity of 2-chloro-2'-deoxyadenosine and 2-bromo-2'-deoxyadenosine on cell growth, clonogenicity, DNA synthesis, and cell cycle kinetics.
    Huang MC; Ashmun RA; Avery TL; Kuehl M; Blakley RL
    Cancer Res; 1986 May; 46(5):2362-8. PubMed ID: 2421877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flow cytometric analysis of adenosine analogue lymphocytotoxicity.
    Kefford RF; Taylor IW; Fox RM
    Cancer Res; 1983 Nov; 43(11):5112-9. PubMed ID: 6577944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purinogenic immunodeficiency diseases. Differential effects of deoxyadenosine and deoxyguanosine on DNA synthesis in human T lymphoblasts.
    Wilson JM; Mitchell BS; Daddona PE; Kelley WN
    J Clin Invest; 1979 Nov; 64(5):1475-84. PubMed ID: 115901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of 2'-deoxycoformycin on the metabolism of purines and the survival of malignant cells in a patient with T-cell leukemia.
    Yu AL; Bakay B; Kung FH; Nyhan WL
    Cancer Res; 1981 Jul; 41(7):2677-82. PubMed ID: 6972800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purine deoxynucleoside toxicity in nondividing human lymphoid cells.
    Kefford RF; Fox RM
    Cancer Res; 1982 Jan; 42(1):324-30. PubMed ID: 6976204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poly(A)+RNA as a possible target for deoxyadenosine induced G1/G0 lymphotoxicity.
    Kefford RF; Fox RM; McCairns E; Fahey D; Muscat GE; Rowe PB
    Adv Exp Med Biol; 1984; 165 Pt B():339-44. PubMed ID: 6202120
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibition of DNA repair by deoxyadenosine in resting human lymphocytes.
    Seto S; Carrera CJ; Wasson DB; Carson DA
    J Immunol; 1986 Apr; 136(8):2839-43. PubMed ID: 2870121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential production of deoxyadenosine by human T and B lymphoblasts.
    Iizasa T; Kubota M; Carson DA
    J Immunol; 1983 Oct; 131(4):1776-9. PubMed ID: 6352803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical correlates of the differential sensitivity of subtypes of human leukemia to deoxyadenosine and deoxycoformycin.
    Matsumoto SS; Yu AL; Bleeker LC; Bakay B; Kung FH; Nyhan WL
    Blood; 1982 Nov; 60(5):1096-102. PubMed ID: 6289941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of deoxynucleosides on cultured human leukemia cell growth and deoxynucleotide pools.
    Ross DD; Akman SA; Schrecker AW; Bachur NR
    Cancer Res; 1981 Nov; 41(11 Pt 1):4493-8. PubMed ID: 6975653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of three T-lymphoid cell lines with distinct sensitivities to deoxyadenosine plus deoxycoformycin.
    Duan DS; Smith W; Sadée W; Cowan MJ
    Thymus; 1992 Feb; 19(1):1-11. PubMed ID: 1373528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analytical DNA flow cytometric analysis of deoxyadenosine toxicity in cultured human leukemic lymphoblasts.
    Fox RM; Tripp EH; Taylor IW
    Mol Pharmacol; 1984 Sep; 26(2):388-94. PubMed ID: 6332978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deoxyadenosine (AdR) inhibition of newly activated lymphocytes: blockade at the G0-G1 interface.
    Redelman D; Bluestein HG; Cohen AH; Depper JM; Wormsley S
    J Immunol; 1984 Apr; 132(4):2030-8. PubMed ID: 6421932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selection of 9-beta-D-arabinofuranosyladenine-resistant human T-lymphoblasts with altered ribonucleotide reductase activity.
    Fridland A
    Cancer Res; 1984 Oct; 44(10):4328-32. PubMed ID: 6380707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of RNA synthesis by deoxyadenosine plus deoxycoformycin in resting lymphocytes.
    Matsumoto SS; Yu J; Yu AL
    J Immunol; 1983 Dec; 131(6):2762-6. PubMed ID: 6196398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of inhibition of DNA synthesis by 2-chlorodeoxyadenosine in human lymphoblastic cells.
    Griffig J; Koob R; Blakley RL
    Cancer Res; 1989 Dec; 49(24 Pt 1):6923-8. PubMed ID: 2573423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of herpes simplex virus replication by purine deoxyribonucleosides.
    North TW
    Cancer Res; 1984 Apr; 44(4):1415-9. PubMed ID: 6322976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.